Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Demant A/S
  6. News
  7. Summary
    DEMANT   DK0060738599

DEMANT A/S

(DEMANT)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 11/26 10:59:36 am
315.2 DKK   -2.60%
11/162020-13 : Financial calendar 2022
AQ
11/02Demant A/S Provides Earnings Guidance for the Second Half of the Year 2021
CI
11/02DEMANT A/S : Interim Management Statement
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Demant A/S: Major shareholder announcement from Canada Pension Plan Investment Board

08/24/2021 | 01:48pm EST

Company announcementno 2021-12

24 August 2021

Major shareholder announcement concerning Canada Pension Plan Investment Board pursuant to section 29 of the Danish Securities Trading Act

Pursuant to section 29 of the Danish Securities Trading Act, Demant hereby makes public that the company has received the following announcement:

Canada Pension Plan Investment Board has in a number of transactions reduced its direct and indirect holding of voting rights and share capital in Demant to below 5% as at 23 August 2021.

 

Further information:

Søren Nielsen, President & CEO

Phone +45 3917 7300

www.demant.com

Other contacts:

René Schneider, CFO

Mathias Holten Møller, Head of Investor Relations

Christian Lange, Investor Relations Officer

Trine Kromann-Mikkelsen, VP Corporate Communication and Relations

 

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments

  • 2021-12 Major Shareholder Announcement.pdf

© Ritzau Denmark, source Ritzau English Regulatory Releases

All news about DEMANT A/S
11/162020-13 : Financial calendar 2022
AQ
11/02Demant A/S Provides Earnings Guidance for the Second Half of the Year 2021
CI
11/02DEMANT A/S : Interim Management Statement
AQ
11/02Demant A/S Revises Earnings Guidance for the Year 2021
CI
10/14DEMANT A/S : Halts Sales for Cochlear Implants Amid Performance Issues
MT
10/14DEMANT A/S : Notification of voluntary field corrective action by the cochlear implants bu..
AQ
09/28Colosseum kits and plastic flowers help Lego's earnings double
RE
09/27DEMANT A/S : Commits To Net-Zero Carbon Emissions By 2050
MT
09/27DEMANT A/S : makes ambitious commitment to take climate action
PU
09/27DEMANT A/S : Capital Markets Day 2021 - Delivering sustained growth post coronavirus
AQ
More news
Analyst Recommendations on DEMANT A/S
More recommendations
Financials
Sales 2021 18 442 M 2 808 M 2 808 M
Net income 2021 2 502 M 381 M 381 M
Net Debt 2021 8 357 M 1 273 M 1 273 M
P/E ratio 2021 29,6x
Yield 2021 -
Capitalization 75 437 M 11 476 M 11 487 M
EV / Sales 2021 4,54x
EV / Sales 2022 4,15x
Nbr of Employees 17 556
Free-Float 41,1%
Chart DEMANT A/S
Duration : Period :
Demant A/S Technical Analysis Chart | DEMANT | DK0060738599 | MarketScreener
Technical analysis trends DEMANT A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 315,20 DKK
Average target price 332,88 DKK
Spread / Average Target 5,61%
EPS Revisions
Managers and Directors
S°ren Nielsen President & Chief Executive Officer
RenÚ Schneider Chief Financial Officer
Niels Bj°rn Christiansen Chairman
Benedikte Leroy Independent Director
Lars S°ren Rasmussen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DEMANT A/S31.01%11 476
STRAUMANN HOLDING AG83.42%32 606
SONOVA HOLDING AG50.57%23 380
COCHLEAR LIMITED19.97%10 616
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.43.69%4 089
ÖSSUR HF.-14.55%2 659